Saturday, November 8, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Market Commentary

Tech Stocks Retreat as Powell’s Caution Tempers Rally

Dieter Jaworski by Dieter Jaworski
September 24, 2025
in Market Commentary, Nasdaq, Tech & Software
0
NASDAQ 100 Stock
0
SHARES
69
VIEWS
Share on FacebookShare on Twitter

The Nasdaq 100 snapped its record-breaking run on Thursday, closing lower after cautious commentary from Federal Reserve Chair Jerome Powell prompted a wave of profit-taking. The technology-heavy index finished the session down 178.94 points, or 0.73%, settling at 24,580.17.

Market Reversal Follows Early Gains

Trading began on a positive note, with the index climbing to an intraday peak of 24,764.30 points shortly after the opening bell. However, the mood shifted decisively following Powell’s remarks. The Fed Chairman jolted investors by stating that equities appear “fairly highly priced” and cautioning that there is “no risk-free path” for monetary policy.

This sentiment triggered a sell-off, dragging the Nasdaq 100 to a daily low of 24,536.50. A modest recovery in the final hour of trading pared some of the session’s losses.

Should investors sell immediately? Or is it worth buying NASDAQ 100?

Broader Market Weakness and Rising Uncertainty

The pullback was not isolated to the tech sector. Broader U.S. equity indices also faced pressure, reflecting a market-wide increase in caution. The S&P 500 declined by 0.6%, while the Dow Jones Industrial Average dipped 0.2%. The growing unease was further evidenced by a rise in the CBOE Volatility Index (VIX), a key gauge of market fear.

The question now facing investors is whether this marks a temporary pause for the market’s leading technology shares or the beginning of a more significant correction. The sustainability of the recent rally will be tested in the coming trading sessions.

Ad

NASDAQ 100 Stock: Buy or Sell?! New NASDAQ 100 Analysis from November 8 delivers the answer:

The latest NASDAQ 100 figures speak for themselves: Urgent action needed for NASDAQ 100 investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 8.

NASDAQ 100: Buy or sell? Read more here...

Tags: NASDAQ 100
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Phunware Stock
AI & Quantum Computing

Can AI Drive a Turnaround for Phunware Stock?

November 8, 2025
Intevac Stock
Mergers & Acquisitions

Intevac Acquisition Finalized as Seagate Completes Takeover

November 8, 2025
Redcare Pharmacy Stock
Analysis

Redcare Pharmacy Shares Plunge Despite Strong Fundamentals

November 8, 2025
Next Post
NextDecade Stock

A Tale of Two Perspectives: NextDecade's Conflicting Signals

HCA Healthcare Stock

HCA Healthcare: Balancing Shareholder Returns with Strategic Growth Initiatives

Sasol Stock

Sasol Shares Face Analyst Scrutiny Amid Cash Flow Concerns

Recommended

Faro Stock

Acquisition Finalized: Faro Shareholders Approve AMETEK’s Premium Buyout

4 weeks ago
Finance_ projections

Insider Stock Sales A Cautionary Tale

2 years ago
Fair Isaac Stock

Fair Isaac’s Bold Strategy Shift Rattles Credit Industry

1 month ago
Schwab U.S. Dividend Equity ETF™ Stock

Navigating Market Divergence: The SCHD Dividend Strategy in Focus

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Oruka Therapeutics Secures Major Funding to Advance Clinical Pipeline

Liberty Uranium Shares Plunge Amid Sustained Selling Pressure

Intevac Acquisition Finalized as Seagate Completes Takeover

Can Emergent BioSolutions Stock Maintain Its Upward Trajectory?

Trinity Biotech Shares Face Persistent Downward Pressure

NovaBridge Biosciences Unveils Promising Clinical Trial Data and Strategic Rebranding

Trending

Alset Stock
Analysis

Alset Shares: Navigating Volatility Between Short-Term Pressure and Long-Term Gains

by Dieter Jaworski
November 8, 2025
0

Alset Inc. shares are currently presenting investors with a complex picture, caught between immediate downward pressure and...

Phunware Stock

Can AI Drive a Turnaround for Phunware Stock?

November 8, 2025
Dare Bioscience Stock

Can Dare Bioscience Stock Reverse Its Fortunes?

November 8, 2025
ARCA biopharma Stock

Oruka Therapeutics Secures Major Funding to Advance Clinical Pipeline

November 8, 2025
Liberty Uranium & Metals Stock

Liberty Uranium Shares Plunge Amid Sustained Selling Pressure

November 8, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Alset Shares: Navigating Volatility Between Short-Term Pressure and Long-Term Gains
  • Can AI Drive a Turnaround for Phunware Stock?
  • Can Dare Bioscience Stock Reverse Its Fortunes?

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com